Oncolytic Virotherapy and Self-Amplifying RNAs for Cancer Therapeutics
As part of our Monday seminar series, we are delighted to welcome our speaker:
Talk title: Oncolytic Virotherapy and Self-Amplifying RNAs for Cancer Therapeutics
Taha Azad PhD
Assistant Professor
Département de microbiologie et d'infectiologie,
Université de Sherbrooke
Hosted By
How to join
The event will be in person only, no need to register.
MSB 2172
Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON M5S 1A8
If you have any questions about this event, please contact Debb Yorke at lmp.chairadmin@utoronto.ca.
Speaker: Taha Azad, PhD
Dr. Taha Azad is an Assistant Professor at the Université de Sherbrooke, specializing in RNA therapeutics, oncolytic viruses, and biosensor development. A recent highlight of Dr. Azad's work is his publication in Nature Biomedical Engineering, introduces a novel cancer immunotherapy approach that leverages oncolytic viruses as targeted delivery vectors. Additionally, in a Nature Communications publication, Dr. Azad and his team introduced synthetic virology approaches to enhance the safety and efficacy of oncolytic virus therapies. Their development of drug-controlled gene switches allows for precise modulation of viral replication and transgene expression, representing a significant advancement in oncolytic virotherapy.
